Multimodality treatment of unresectable stage III non-small cell lung cancer: Interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy

Journal of Thoracic and Cardiovascular Surgery

Volumn 131, Issue 2, 2006, Pages

  Galetta, Domenico ^a   Cesario, Alfredo ^b,d   Margaritora, Stefano ^b   Porziella, Venanzio ^b   Piraino, Alessio ^b   D'Angelillo, Rolando M ^c   Gambacorta, Maria A ^c   Ramella, Sara ^c   Trodella, Lucio ^c   Valente, Salvatore ^c   Corbo, Giuseppe M ^c   Macis, Giuseppe ^c   Mulè, Antonino ^c   Cardaci, Vittorio ^e   Sterzi, Silvia ^f   Granone, Pierluigi ^b   Russo, Patrizia ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d Hospitalization and Healthcare   (Italy)

^e Scientific Institute   (Italy)

^f UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ESOPHAGUS DISEASE; FEMALE; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PREOPERATIVE CARE; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 31044440383     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2005.07.044     Document Type: Article

References (30)

1. American Cancer Society [ http://www.cancer.org/ ]. Cancer Facts & Figures 2004. Accessed 2004 June 2. Available from: http://www.cancer.org/ downloads/STT/CAFF_finalPWSecured.pdf
2. C.F. Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
3. D.G. Pfister, D.H. Johnson, C.G. Azzoli, W. Sause, T.J. Smith, S. Baker Jr American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline update 2003 J Clin Oncol. 22 2004 330 353
4. D.R. Gandara, H. West, K.S. Albain, M.W. Wasik, J.C. Crowley, H. Choy Defining the role of radiation therapy in combination with preoperative chemotherapy in stage iii non-small cell lung cancer rationale and design of a new intergroup study Proc Am Soc Clin Oncol. 2004 458 462
5. L. Trodella, P. Granone, S. Valente, S. Margaritora, G. Macis, A. Cesario Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer long-term results according to downstaging Ann Oncol. 15 2004 389 398
6. J.R. Sonett, M.J. Krasna, M. Suntharalingam, J. Schuetz, L.A. Doyle, M. Lilenbaum Safe pulmonary resection after chemotherapy and high-dose thoracic radiation Ann Thorac Surg. 68 1999 316 320
7. M. Machtay, J.H. Lee, J.P. Stevenson, J.B. Shrager, K.M. Algazy, J. Treat Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma Long-term results and associations with pathologic response J Thorac Cardiovasc Surg. 127 2004 108 113
8. H.I. Pass, H.W. Pogrebniak, S.M. Steinberg, J. Mulshine, J. Minna Randomized trial of neoadjuvant therapy for lung cancer interim analysis Ann Thorac Surg. 53 1992 992 998
9. J.A. Roth, F. Fossella, R. Komaki, M.B. Ryan, J.B. Putnam Jr, J.S. Lee A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer J Natl Cancer Inst. 86 1994 673 680
10. R. Rosell, J. Gomez-Codina, C. Camps, J. Javier Sanchez, J. Maestre, J. Padilla Preresectional chemotherapy in stage IIIA non-small-cell lung cancer a 7-year assessment of a randomized controlled trial Lung Cancer 267 1999 7 14
11. C.C. Pitz, K.W. Maas, H.A. Van Swieten, A.B. de la Riviere, P. Hofman, F.M. Schramel Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer Ann Thorac Surg. 74 2002 164 169
12. M. Rinaldi, L. Crino Induction chemotherapy with gemcitabine and cisplatin in stage III non-small cell lung cancer Lung Cancer 34 Suppl4 2001 S25 S30
13. N. Van Zandwijk, E.F. Smit, G.W. Kramer, F. Schramel, S. Gans, J. Festen Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955) J Clin Oncol. 18 2000 2658 2664
14. M.S. Aapro, C. Martin, S. Hatty Gemcitabine - a safety overview Anticancer Drugs 9 1998 191 201
15. D.S. Shewach, T.S. Lawrence Radiosensitization of human solid tumor cell lines with gemcitabine Semin Oncol. 23 5 Suppl 10 1996 65 71
16. S. Pacini, F. Milano, P. Pinzani, M. Pazzagli, M. Gulisano, M. Ruggiero Effects of gemcitabine in normal and transformed human lung cell cultures cytotoxicity and increase in radiation sensitivity Tumori. 85 1999 503 507
17. T.S. Lawrence, A. Eisbruch, C.J. McGinn, M.T. Fields, D.S. Shewach Radiosensitization by gemcitabine Oncology (Williston Park) 13 10 Suppl 5 1999 55 60
18. A. Argiris, M. Liptay, M. LaCombe, M. Marymont, M.S. Kies, S. Sundaresan A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer Lung Cancer 45 2004 243 253
19. L. Trodella, P. Granone, S. Valente, A. Turriziani, G. Macis, G.M. Corbo Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer J Clin Oncol. 20 2002 804 810
20. K.S. Albain, V.W. Rusch, J.J. Crowley, T.W. Rice, A.T. Turrisi 3rd, J.K. Weick Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer mature results of Southwest Oncology Group phase II study 8805 J Clin Oncol. 13 1995 1880 1892
21. D.J. Sugarbaker, J. Herndon, L.J. Kohman, M.J. Krasna, M.R. Green Cancer and Leukemia Group B Thoracic Surgery Group Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer J Thorac Cardiovasc Surg. 109 1995 473 483
22. K.S. Albain, C.B. Scott, V.R. Rusch, A.T. Turrisi, F.A. Shepherd, C. Smith RTOG, SWOG, NCIC, ECOG, CALGB, NCCTG Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC) initial results from intergroup trial 0139 (RTOG 93-09) [abstract 2497] Proc Am Soc Clin Oncol. 22 2003 621
23. J. Martin, R.J. Ginsberg, E.S. Venkatraman, M.S. Bains, R.J. Downey, R.J. Korst Long-term results of combined-modality therapy in resectable non-small-cell lung cancer J Clin Oncol. 20 2002 1989 1995
24. D.C. Betticher, S.F. Hsu Schmitz, M. Totsch, E. Hansen, C. Joss, C. von Briel Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer a multicenter phase II trial J Clin Oncol. 21 2003 1752 1759
25. N.C. Choi, R.W. Carey, W. Daly, D. Mathisen, J. Wain, C. Wright Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer J Clin Oncol. 15 1997 712 722
26. D.R. Gandara, K. Chansky, K.S. Albain, B.R. Leigh, L.E. Gaspar, P.N. Lara Jr Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer phase II Southwest Oncology Group Study S9504 J Clin Oncol. 21 2003 2004 2010
27. P. Granone, A. Cesario, S. Margaritora, D. Galetta, S. Valente, G.M. Corbo Morbidity after induction therapy and surgery in non small cell lung cancer (NSCLC). Focus on pulmonary function Lung Cancer 36 2002 219 220
28. C. Doddoli, P. Thomas, X. Thirion, Y. Seree, R. Giudicelli, P. Fuentes Post-operative complications in relation with induction therapy for lung cancer Eur J Cardiothorac Surg. 20 2001 385 390
29. D.H. Grunenwald, F. Andre, C. Le Pechoux, P. Girard, C. Lamer, A. Laplanche Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer J Thorac Cardiovasc Surg. 122 2001 796 802
30. G.M. Strauss, J.E. Herndon, D.D. Sherman, D.J. Mathisen, R.W. Carey, N.C. Choi Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung report of a Cancer and Leukemia Group B phase II study J Clin Oncol. 10 1992 1237 1244